Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cerilliant
Chinese Patent Office
UBS
Mallinckrodt
Federal Trade Commission
Moodys
Accenture
Boehringer Ingelheim

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018086

« Back to Dashboard

NDA 018086 describes TIMOPTIC, which is a drug marketed by Aton and Valeant Pharms Llc and is included in three NDAs. It is available from two suppliers. Additional details are available on the TIMOPTIC profile page.

The generic ingredient in TIMOPTIC is timolol maleate. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the timolol maleate profile page.
Summary for 018086
Tradename:TIMOPTIC
Applicant:Aton
Ingredient:timolol maleate
Patents:0
Therapeutic Class:Antimigraine Agents
Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 018086
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 018086
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TIMOPTIC timolol maleate SOLUTION/DROPS;OPHTHALMIC 018086 NDA Bausch & Lomb Incorporated 24208-812 N 24208-812-05
TIMOPTIC timolol maleate SOLUTION/DROPS;OPHTHALMIC 018086 NDA Bausch & Lomb Incorporated 24208-813 N 24208-813-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.5% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:AT1RLD:Yes

Expired US Patents for NDA 018086

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton TIMOPTIC timolol maleate SOLUTION/DROPS;OPHTHALMIC 018086-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Aton TIMOPTIC timolol maleate SOLUTION/DROPS;OPHTHALMIC 018086-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Aton TIMOPTIC timolol maleate SOLUTION/DROPS;OPHTHALMIC 018086-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Aton TIMOPTIC timolol maleate SOLUTION/DROPS;OPHTHALMIC 018086-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Chubb
Harvard Business School
Deloitte
Covington
Teva
Fuji
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.